GEN - Genetic Engineering & Biotech NewsOriginal article
Crohn’s Disease Phage Therapy Neutralizes Inflammatory E. coli in Mouse Model
Phase 1positiveBacteriophage TherapyPositive
AI Analysis
Summary
Researchers developed a bacteriophage therapy that in a mouse model neutralized inflammatory E. coli and improved responses to low-dose corticosteroids, supporting potential treatment for Crohn's disease. This is preclinical data with no identified company or clinical trial identifier.
Clinical Trial Data
Phase
Preclinical
Primary Endpoint
Met
Outcome Details
Phage therapy neutralized inflammatory E. coli in mouse model and improved responses to low-dose corticosteroid
Importance:3/10
Sentiment:
0.60
Phage TherapyCrohn's DiseasePreclinicalE. coliInflammatory Bowel DiseaseGut Health
Related Companies
Read the original article
Published by GEN - Genetic Engineering & Biotech News on July 9, 2026 7:12 PM